Open AccessSession of the Cardiology Research Center of the Russian Academy of Medical Sciences
Author(s) -
И. А. Латфуллин,
I. P. Arleevsky
Publication year - 1996
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj104371
Subject(s) - session (web analytics) , medicine , position (finance) , library science , political science , business , finance , advertising , computer science
Another session of KRC RAMS began with a Russian-French symposium devoted to the use of the new -blocker lokren (betaxololol) in the treatment of arterial hypertension (AH). As the chairman of the symposium prof. Y.N. Belenkov (Moscow) noted, the continuing interest to the search of new tools for AH treatment is caused primarily by the fact that our country annually loses over 500 thousand people from AH and its complications. The available arsenal of hypotensive drugs is thoroughly reconsidered from the position of modern views on the pathogenesis of AH and the influence of these drugs on the quality of life.